Similar articles for PMID: 10864055

Year	Number of Results
1989	1
1991	2
1992	3
1993	3
1994	4
1995	6
1996	3
1997	7
1998	11
1999	11
2000	10
2001	14
2002	9
2003	1
2004	7
2005	4
2006	3
2007	2
2008	3
2009	2
2010	2
2011	2
2012	4
2013	3
2014	3
2017	1
2018	2
2020	2
2021	3
2024	0

1

Use of amphotericin B colloidal dispersion in children.

Sandler ES, Mustafa MM, Tkaczewski I, Graham ML, Morrison VA, Green M, Trigg M, Abboud M, Aquino VM, Gurwith M, Pietrelli L. Sandler ES, et al. J Pediatr Hematol Oncol. 2000 May-Jun;22(3):242-6. doi: 10.1097/00043426-200005000-00009. J Pediatr Hematol Oncol. 2000. PMID: 10864055 Clinical Trial.

2

Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia.

White MH, Bowden RA, Sandler ES, Graham ML, Noskin GA, Wingard JR, Goldman M, van Burik JA, McCabe A, Lin JS, Gurwith M, Miller CB. White MH, et al. Clin Infect Dis. 1998 Aug;27(2):296-302. doi: 10.1086/514672. Clin Infect Dis. 1998. PMID: 9709879 Clinical Trial.

3

Amphotericin-B colloidal dispersion. A review of its use against systemic fungal infections and visceral leishmaniasis.

Brogden RN, Goa KL, Coukell AJ. Brogden RN, et al. Drugs. 1998 Sep;56(3):365-83. doi: 10.2165/00003495-199856030-00008. Drugs. 1998. PMID: 9777313 Review.

4

Amphotericin B colloidal dispersion.

Patel R. Patel R. Expert Opin Pharmacother. 2000 Mar;1(3):475-88. doi: 10.1517/14656566.1.3.475. Expert Opin Pharmacother. 2000. PMID: 11249532 Review.

5

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS. Walsh TJ, et al. N Engl J Med. 1999 Mar 11;340(10):764-71. doi: 10.1056/NEJM199903113401004. N Engl J Med. 1999. PMID: 10072411 Free article. Clinical Trial.

6

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.

Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE. Walsh TJ, et al. N Engl J Med. 2004 Sep 30;351(14):1391-402. doi: 10.1056/NEJMoa040446. N Engl J Med. 2004. PMID: 15459300 Free article. Clinical Trial.

7

Safety of amphotericin B colloidal dispersion.

Herbrecht R. Herbrecht R. Eur J Clin Microbiol Infect Dis. 1997 Jan;16(1):74-80. doi: 10.1007/BF01575124. Eur J Clin Microbiol Infect Dis. 1997. PMID: 9063677 Clinical Trial.

8

Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation.

Krüger W, Stockschläder M, Sobottka I, Betker R, De Wit M, Kröger N, Grimm J, Arland M, Fiedler W, Erttmann R, Zander AR. Krüger W, et al. Leuk Lymphoma. 1997 Feb;24(5-6):491-9. doi: 10.3109/10428199709055586. Leuk Lymphoma. 1997. PMID: 9086439 Clinical Trial.

9

Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability.

Tiphine M, Letscher-Bru V, Herbrecht R. Tiphine M, et al. Transpl Infect Dis. 1999 Dec;1(4):273-83. doi: 10.1034/j.1399-3062.1999.010406.x. Transpl Infect Dis. 1999. PMID: 11428998 Review.

10

Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients.

Noskin G, Pietrelli L, Gurwith M, Bowden R. Noskin G, et al. Bone Marrow Transplant. 1999 Apr;23(7):697-703. doi: 10.1038/sj.bmt.1701630. Bone Marrow Transplant. 1999. PMID: 10218847 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

125 results

Results by year